Replies to post #346475 on Amarin Corp Plc (AMRN)

[Jasbg]

raf, Constructive criticism - you say' - and I have thought about that reply.
-------------------------------

1: Many point to Amarins +500 - +800 reps in the US market (numbers vary from different posters).

Giving a little thought to that reply - the next logical question would be': 'How many reps do Teva - Hikma - Dr. Reddy have in the US ?

Any one have any idea to that ?
----------------------------------------

World is changing - possibly more rapidly than ever' after Covid pandemic attach.

2: Is applying hundreds of (very expensive) reps the right way to move forward in an environment - where the internet 'Rules the World' - eg. where this debate is taking place - this moment ?
-----------------------------------

3. Could direct invitations to hundreds of Doctors to 2-3 day 'free weekend Couse on Vascepa' (with wife's) - hiring Bhatt to inspire maybe be a better way forward for marketing 2021 ?

Jasbg

[Birdbrain Ideas]

This in no way is a criticism. You are a prince for supplying these stats each week.

But I wonder if it might make sense to say in plain English at the start of scripts: "New scripts" or "Refills" rather than the shorthand references.

Hopefully, Amarin's stock price will begin ascending rather than descending in the coming months as sales pick up in the U.S. and sales begin in Europe and hundreds of new folks will explore this board. Many of them, presumably, will know little about pharmaceutical stocks but will be intrigued by a company that reduces heart attacks and strokes, plaque in arteries and perhaps Alzheimer's.

Thus, after all the work you do to assemble this fantastic information, it would be great to spell out plainly what the scripts we're referencing are. At the very least, it would eliminate the many posts I've seen the past few years by newbies asking what the acronyms mean. All the best!